NEWTOWN, Pa. & ANN ARBOR, Mich.----CollaGenex Pharmaceuticals, Inc. and QuatRx Pharmaceuticals Company today announced a licensing agreement under which CollaGenex will develop and commercialize becocalcidiol, a patented Vitamin D analogue developed by QuatRx that is currently in Phase II clinical trials for the topical treatment of mild to moderate psoriasis.
From: biz.yahoo.com
CollaGenex Pharmaceuticals and QuatRx Pharmaceuticals Announce Agreement for the Development and Commercialization of ...
Posted by Ruslan Abuzant at 6:15 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment